1137226

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 16, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)